LANSING, Mich. — Lansing company, Niowave, has been approved to receive federal funding to create an important product used in healthcare.
The announcement came out Thursday morning from the Department of Energy.
Mo-99 is a medical isotope that is vital to the medical field.
“Mo-99 is such a critical tool in healthcare. Doctors count on it every day,” said U.S. Secretary of Energy Rick Perry. “This industry outreach helps to develop a reliable domestic supply of a vital medical isotope, reduce dependence on foreign imports, and bring new opportunity to the heartland.”
It is used in over 40,000 medical procedures in the U.S. every day to diagnose heart disease and cancer, also to study organ structure and function, and for other medical applications.
And with support from Congress, Niowave, Inc. of Lansing will receive up to $15 million to produce the product without the use of highly enriched uranium (HEU).
Niowave is one of four companies across the U.S. to win the contract.
For more information on DOE/NNSA efforts to establish a reliable supply of Mo‑99 without the use of HEU, click here.
